Results 61 to 70 of about 254,699 (197)

Iodinated contrast media and cerebral hemorrhage after intravenous thrombolysis [PDF]

open access: yes, 2011
<p>Background and Purpose: Iodinated contrast is increasingly used in CT perfusion or angiographic examinations in acute stroke. Increased risk of intracranial hemorrhage (ICH) complicating microcatheter contrast injections has recently been ...
McVerry, F.   +11 more
core   +1 more source

Clinical Characteristics and Prognosis of ICU-Admitted Patients with Guillain-Barre Syndrome: A Report from a Large Teaching Hospital in South Iran [PDF]

open access: yesIranian Journal of Medical Sciences
Background: Guillain-Barre Syndrome (GBS) is the most prevalent acute peripheral polyneuropathy disorder. The disparities between populations and variations in the major risk factors highlight the importance of country-specific studies.
Vida Naderi-boldaji   +7 more
doaj   +1 more source

[Intravenous immunoglobulins. General features and the main clinical applications].

open access: yes, 1992
Intravenous immunoglobulins are stable pooled human IgG preparations for therapeutic use. Intravenous immunoglobulins are used for replacement therapy for patients with primary or secondary antibody immunodeficiency, and they are also beneficial in the ...
Agostini G, ANTONELLI, ALESSANDRO
core  

Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies

open access: yes, 2009
Intravenous immunoglobulins (IVIg) have been shown in a number of trials, to be an effective treatment for the three main types of inflammatory neuropathies: Guillain-Barré Syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and ...
Jacob, Saiju; id_orcid   +1 more
core   +1 more source

Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases

open access: yes, 1991
SUMMARY Intravenous immunoglobulin (IVIg) therapy is increasingly used in autoimmune diseases. Although its efficacy has only been established in a few specific antibody-mediated autoimmune conditions, accumulating evidence on the ...
V HUREZ   +3 more
core   +1 more source

Clinical Use of Intravenous Immunoglobulins

open access: yes, 1986
xx;460hal ...
Morell,A and Nydegger, U.E
core  

Secondary hypogammaglobulinemia in Waldmann's disease treated with subcutaneous immunoglobulins [PDF]

open access: yes, 2016
Primary intestinal lymphangiectasia (PIL) is rare disorder characterized by congenital malformation or obstruction of intestinal lymphatic drainage; it is responsible for protein losing enteropathy leading to lymphopenia, hypoalbuminemia and ...
PATUZZO, Giuseppe   +4 more
core   +3 more sources

Effect of Intravenous Immunoglobulin in Reducing Bilirubin Levels in Hemolytic Disease of Newborn

open access: yesJournal of Rawalpindi Medical College, 2013
Background: To assess the efficacy of intravenous immunoglobulins in reducing the duration of phototherapy and the need for exchange transfusion in neonates with Rh and/or ABO incompatibility. Methods: In this descriptive study 60 patients diagnosed with
Saba Naim Khan
doaj  

Adverse reactions of intravenous immunoglobulin

open access: yesSaudi Medical Journal, 2000
OBJECTIVE: To study the frequency, type, and severity of adverse reactions to intravenous immunoglobulin infusions and possible preventable measures. METHODS: We prospectively studied the frequency, type, and severity of adverse reactions in 104 intravenous immunoglobulin infusions (IntraglobinTMF) given to 13 patients suffering from several ...
A M, Al-Wahadneh   +2 more
openaire   +2 more sources

Thymoma complicated with myasthenia gravis and Good syndrome – a therapeutic conundrum: a case report

open access: yesJournal of Medical Case Reports, 2019
Background Thymomas are known to be associated with myasthenia gravis and Good syndrome. Good syndrome is the association of thymoma with combined B cell and T cell immunodeficiency. The combination of all three diseases has not been reported. We discuss
Shiran Paranavitane   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy